Ketamine-Propofol vs Dexmedetomidine-Propofol Sedation for Pediatric Cardiac Catheterization
Official title: a Comparive Study of Ketamine-Propofol Versus Dexmedetomidine-Propofol Sedation in Pediatric Patients Undergoing Cardiac Catheterization for Device Closure of Simple Left-to-right Shunts
Run by Ain Shams University · NCT07669012 · Data updated 2026-11-12
This study tests two sedative combinations to see which is safer and more effective for children 2–12 undergoing device closure of simple left-to-right heart shunts.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 2 Years to 12 Years |
| Sex | All |
| Enrollment | 124 (estimated) |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | October 22, 2025 |
| Main results expected | October 22, 2026 |
| Study ends | February 15, 2027 |
| Registry record updated | June 25, 2026 |
| Trial ID | NCT07669012 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 2–12 years, ≥10 kg, ASA II-III, scheduled for elective transcatheter closure of a simple left-to-right shunt such as ASD, small VSD, or PDA, and whose guardians consent to participation.
✕Probably not a fit
Patients with cyanotic heart disease, complex congenital lesions, or those requiring general anesthesia with a cuffed endotracheal tube may not benefit from these specific sedation regimens.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional Phase 1 trial compares ketamine-propofol with dexmedetomidine-propofol sedation in children undergoing transcatheter device closure of simple left-to-right shunts. Eligible participants are 2–12 years old, weighing at least 10 kg, with ASA II-III status, and scheduled for elective closure of conditions such as ASD, small muscular VSD, or PDA. Procedures may be guided by transthoracic or transesophageal echocardiography per the cardiology team's practice. The study aims to assess safety and efficacy of the two sedation regimens during the catheterization procedure. Lead sponsor is Ain Shams University, with procedures conducted at Ain Shams University Hospital in Cairo, Egypt.
Why it matters
Potential benefit: If successful, the trial could identify a preferred sedation approach that improves safety and comfort for pediatric patients undergoing device closure procedures.
How similar studies have gone: Sedation with ketamine-propofol and dexmedetomidine-propofol has been explored in pediatric procedural settings, but direct head-to-head comparisons for this specific device-closure context are limited, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 2-12 years, male or female * Weight ≥ 10 kg * Scheduled for elective transcatheter device closure of a simple left-to-right shunt, including: * Secundum atrial septal defect (ASD) suitable for device closure * Small muscular ventricular septal defect (VSD) eligible for percutaneous device closure * Patent ductus arteriosus (PDA) closure * Procedure performed with transthoracic or transesophageal echocardiographic guidance according to the cardiology team's practice * ASA physical status II-III * Written informed consent obtained from a parent or legal guardian Exclusion Criteria: * Cyanotic congenital heart disease * Complex congenital cardiac lesions * Risk of pulmonary hypertensive crisis * Requirement for general anesthesia and cuffed endotracheal tube at the discretion of the cardiology or anesthesia team * Baseline oxygen requirement \> 2 L/min * Use of noninvasive ventilation * Known allergy or intolerance to ketamine, dexmedetomidine, or propofol * Significant hepatic impairment * Significant renal impairment * Advanced atrioventricular block * Clinically significant bradyarrhythmia * Uncontrolled epilepsy * Raised intracranial pressure * Severe obstructive sleep apnea * Craniofacial anomalies associated with anticipated difficult airway management * BMI \> 97th percentile when judged to confer high risk of sedation-related airway obstruction * Current beta-blocker use * Current clonidine use * Acute upper respiratory tract infection within 2 weeks before the procedure * Emergency or add-on procedures * Anticipated procedure duration \< 20 minutes * Anticipated procedure duration \> 3 hours
Where it's running
-
Ain shams university hospital
Cairo, Egypt Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Impact of Anesthesia on Inflammation and NETosis During HCC Ablation
This study tests whether a propofol–fentanyl anesthesia plan with lidocaine during radiofrequency ablation for hepatocellular carcinoma affects inflammation and NETosis in patients with small tumors.
-
IR-led deep ketamine sedation for select image-guided procedures
We will try deep ketamine sedation instead of general anesthesia for adults having certain image-guided interventional radiology procedures.
-
Cannabis use and IV sedation during wisdom tooth removal
This project will see if people who use cannabis need different IV sedative doses or have different vital signs and breathing during wisdom tooth removal compared with people who don't use cannabis.
-
Brain‑wave and pain‑signal monitoring during anesthesia for ERCP to map opioid and sedative effects
This trial will test whether continuous brain‑wave (EEG/PSI) and heart‑rate variability (ANI) monitoring during targeted infusions of opioids and sedatives can show how those drugs interact in people having ERCP under general anesthesia.
-
How common pain is in adults on mechanical ventilators in intensive care units
The researchers will measure how often adults on invasive mechanical ventilation in ICUs experience pain and which clinical factors are linked to it.
-
No continuous sedation versus daily sedation interruption for ventilated COPD patients
This compares no continuous sedation to daily sedation breaks to see which approach gives more ventilator-free days for adults with COPD on a breathing machine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.